

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * actin-myosin filament sliding (GO:0033275) | 9.56535210 |
| 2 | * muscle filament sliding (GO:0030049) | 9.56535210 |
| 3 | * sarcomere organization (GO:0045214) | 9.09286109 |
| 4 | * cardiac myofibril assembly (GO:0055003) | 8.64251495 |
| 5 | * actin-mediated cell contraction (GO:0070252) | 8.07699634 |
| 6 | * myofibril assembly (GO:0030239) | 7.88838283 |
| 7 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.34217786 |
| 8 | * cardiac muscle contraction (GO:0060048) | 7.16799393 |
| 9 | regulation of skeletal muscle contraction (GO:0014819) | 6.98559927 |
| 10 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.85032040 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.81253564 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.77579878 |
| 13 | * cardiac muscle tissue morphogenesis (GO:0055008) | 6.74147354 |
| 14 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.45939260 |
| 15 | * cardiac muscle cell development (GO:0055013) | 6.38997218 |
| 16 | * actomyosin structure organization (GO:0031032) | 6.24414251 |
| 17 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 6.12717330 |
| 18 | * muscle tissue morphogenesis (GO:0060415) | 6.10369231 |
| 19 | * actin filament-based movement (GO:0030048) | 6.08752377 |
| 20 | * cardiac muscle hypertrophy (GO:0003300) | 6.04888790 |
| 21 | * cardiac cell development (GO:0055006) | 6.02574938 |
| 22 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.01890603 |
| 23 | * striated muscle contraction (GO:0006941) | 5.98196123 |
| 24 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.87565158 |
| 25 | heart process (GO:0003015) | 5.77726193 |
| 26 | heart contraction (GO:0060047) | 5.77726193 |
| 27 | regulation of actin filament-based movement (GO:1903115) | 5.75573621 |
| 28 | * striated muscle hypertrophy (GO:0014897) | 5.74991178 |
| 29 | plasma membrane repair (GO:0001778) | 5.74513217 |
| 30 | regulation of sarcomere organization (GO:0060297) | 5.67403141 |
| 31 | response to muscle activity (GO:0014850) | 5.65908601 |
| 32 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.50359127 |
| 33 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.44215174 |
| 34 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.38558788 |
| 35 | regulation of striated muscle contraction (GO:0006942) | 5.20216794 |
| 36 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 5.18861310 |
| 37 | tricarboxylic acid cycle (GO:0006099) | 5.12705350 |
| 38 | regulation of the force of heart contraction (GO:0002026) | 5.12523282 |
| 39 | * muscle hypertrophy (GO:0014896) | 5.06475083 |
| 40 | * regulation of relaxation of muscle (GO:1901077) | 5.01357417 |
| 41 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.00427895 |
| 42 | carnitine shuttle (GO:0006853) | 4.89366121 |
| 43 | regulation of cell communication by electrical coupling (GO:0010649) | 4.75322025 |
| 44 | heart trabecula formation (GO:0060347) | 4.74267260 |
| 45 | regulation of cardioblast differentiation (GO:0051890) | 4.71748514 |
| 46 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.68551574 |
| 47 | cell communication involved in cardiac conduction (GO:0086065) | 4.67239939 |
| 48 | * adult heart development (GO:0007512) | 4.66247434 |
| 49 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.62661975 |
| 50 | cell communication by electrical coupling (GO:0010644) | 4.62418529 |
| 51 | skeletal muscle adaptation (GO:0043501) | 4.60564092 |
| 52 | muscle cell cellular homeostasis (GO:0046716) | 4.53538552 |
| 53 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.50007824 |
| 54 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.48759096 |
| 55 | creatine metabolic process (GO:0006600) | 4.44893488 |
| 56 | myotube cell development (GO:0014904) | 4.42826662 |
| 57 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.35737381 |
| 58 | muscle hypertrophy in response to stress (GO:0003299) | 4.35737381 |
| 59 | cardiac muscle adaptation (GO:0014887) | 4.35737381 |
| 60 | skeletal muscle fiber development (GO:0048741) | 4.30962448 |
| 61 | fatty acid transmembrane transport (GO:1902001) | 4.26670927 |
| 62 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.26234812 |
| 63 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.19935213 |
| 64 | regulation of ATPase activity (GO:0043462) | 4.15444966 |
| 65 | regulation of ATP catabolic process (GO:1903289) | 4.15444966 |
| 66 | cardiac muscle cell action potential (GO:0086001) | 4.13893797 |
| 67 | skeletal muscle contraction (GO:0003009) | 4.13552104 |
| 68 | regulation of membrane repolarization (GO:0060306) | 4.11542591 |
| 69 | relaxation of muscle (GO:0090075) | 4.04810213 |
| 70 | skeletal muscle tissue development (GO:0007519) | 4.04395164 |
| 71 | response to inactivity (GO:0014854) | 4.04362726 |
| 72 | regulation of cardiac muscle contraction (GO:0055117) | 4.01052978 |
| 73 | * muscle fiber development (GO:0048747) | 3.98338618 |
| 74 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.97001281 |
| 75 | response to caffeine (GO:0031000) | 3.96552439 |
| 76 | regulation of heart rate (GO:0002027) | 3.91473479 |
| 77 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.91450378 |
| 78 | NADH metabolic process (GO:0006734) | 3.88984704 |
| 79 | negative regulation of protein localization to cell surface (GO:2000009) | 3.87067966 |
| 80 | * striated muscle cell development (GO:0055002) | 3.86058733 |
| 81 | relaxation of cardiac muscle (GO:0055119) | 3.84521107 |
| 82 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.84059674 |
| 83 | * muscle contraction (GO:0006936) | 3.83132398 |
| 84 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.81384515 |
| 85 | ATP synthesis coupled proton transport (GO:0015986) | 3.81384515 |
| 86 | muscle adaptation (GO:0043500) | 3.78414158 |
| 87 | regulation of myoblast differentiation (GO:0045661) | 3.77999665 |
| 88 | glycogen catabolic process (GO:0005980) | 3.75788115 |
| 89 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.70670408 |
| 90 | regulation of muscle contraction (GO:0006937) | 3.69740836 |
| 91 | muscle cell fate commitment (GO:0042693) | 3.62871100 |
| 92 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.61021079 |
| 93 | * muscle system process (GO:0003012) | 3.60960729 |
| 94 | regulation of cofactor metabolic process (GO:0051193) | 3.60692965 |
| 95 | regulation of coenzyme metabolic process (GO:0051196) | 3.60692965 |
| 96 | oxidative phosphorylation (GO:0006119) | 3.58251960 |
| 97 | response to epinephrine (GO:0071871) | 3.56866043 |
| 98 | cardiac chamber formation (GO:0003207) | 3.55427214 |
| 99 | striated muscle atrophy (GO:0014891) | 3.54598432 |
| 100 | carnitine transmembrane transport (GO:1902603) | 3.53158088 |
| 101 | glucan catabolic process (GO:0009251) | 3.53075154 |
| 102 | striated muscle adaptation (GO:0014888) | 3.52868731 |
| 103 | muscle structure development (GO:0061061) | 3.51285842 |
| 104 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.50913739 |
| 105 | muscle organ development (GO:0007517) | 3.49864321 |
| 106 | skeletal muscle tissue regeneration (GO:0043403) | 3.49833218 |
| 107 | regulation of heart contraction (GO:0008016) | 3.49774387 |
| 108 | ventricular cardiac muscle cell development (GO:0055015) | 3.49274068 |
| 109 | positive regulation of myoblast differentiation (GO:0045663) | 3.45410193 |
| 110 | positive regulation of cation channel activity (GO:2001259) | 3.43969234 |
| 111 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.43128366 |
| 112 | glucan biosynthetic process (GO:0009250) | 3.40505323 |
| 113 | glycogen biosynthetic process (GO:0005978) | 3.40505323 |
| 114 | atrial septum morphogenesis (GO:0060413) | 3.37132771 |
| 115 | cellular response to epinephrine stimulus (GO:0071872) | 3.35890049 |
| 116 | cellular polysaccharide catabolic process (GO:0044247) | 3.35823614 |
| 117 | cardiac conduction (GO:0061337) | 3.33104157 |
| 118 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.31895321 |
| 119 | * muscle cell development (GO:0055001) | 3.31605264 |
| 120 | * regulation of muscle system process (GO:0090257) | 3.30415850 |
| 121 | positive regulation of heart rate (GO:0010460) | 3.30189410 |
| 122 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 3.29820508 |
| 123 | negative regulation of potassium ion transport (GO:0043267) | 3.29629095 |
| 124 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.27654804 |
| 125 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.22532014 |
| 126 | trabecula formation (GO:0060343) | 3.20532431 |
| 127 | amino-acid betaine transport (GO:0015838) | 3.19959708 |
| 128 | carnitine transport (GO:0015879) | 3.19959708 |
| 129 | positive regulation of cardiac muscle tissue development (GO:0055025) | 3.16337882 |
| 130 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.14278363 |
| 131 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.14278363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 6.55877796 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.23207578 |
| 3 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.32499301 |
| 4 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.32499301 |
| 5 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 4.07812595 |
| 6 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 4.01062930 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.85035734 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.83246006 |
| 9 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.80574575 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.47080404 |
| 11 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 3.08604352 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.05470363 |
| 13 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.89184326 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.83933728 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.68159771 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.61148811 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.56215791 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.40411818 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.30006763 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.29884670 |
| 21 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.23954544 |
| 22 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 2.19039513 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.16881279 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.15031205 |
| 25 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.94897424 |
| 26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.80050180 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 1.78744595 |
| 28 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.66504658 |
| 29 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.64676265 |
| 30 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55240379 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.51898827 |
| 32 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.50467275 |
| 33 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.50372386 |
| 34 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.47327236 |
| 35 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46670765 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45025746 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44693015 |
| 38 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.44146692 |
| 39 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.42552955 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40247314 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39779251 |
| 42 | CJUN_26792858_Chip-Seq_BT549_Human | 1.38773107 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37793196 |
| 44 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.36797521 |
| 45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.35386892 |
| 46 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.34560998 |
| 47 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.32505526 |
| 48 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31243153 |
| 49 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28947726 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27473495 |
| 51 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.27273675 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26626659 |
| 53 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26339682 |
| 54 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.26309069 |
| 55 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.26134377 |
| 56 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.25330973 |
| 57 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.22970719 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22626411 |
| 59 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.21490555 |
| 60 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.21124408 |
| 61 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.20942337 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.20351236 |
| 63 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.16011789 |
| 64 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14722947 |
| 65 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.14688582 |
| 66 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14176623 |
| 67 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13532700 |
| 68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12178178 |
| 69 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11413368 |
| 70 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10933272 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.10927129 |
| 72 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.08593556 |
| 73 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.08500782 |
| 74 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07385742 |
| 75 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07348271 |
| 76 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06649158 |
| 77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06361033 |
| 78 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.05911568 |
| 79 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.05374962 |
| 80 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05147878 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04326008 |
| 82 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.02963290 |
| 83 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02313678 |
| 84 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01999853 |
| 85 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01919876 |
| 86 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01524211 |
| 87 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01412460 |
| 88 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01203630 |
| 89 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01184686 |
| 90 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00678334 |
| 91 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00627757 |
| 92 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99841133 |
| 93 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99587088 |
| 94 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.99122491 |
| 95 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98945421 |
| 96 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98632915 |
| 97 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.98303291 |
| 98 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97873338 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96639921 |
| 100 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.96364665 |
| 101 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95190003 |
| 102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95185470 |
| 103 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.94970049 |
| 104 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94235111 |
| 105 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.93663788 |
| 106 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93238993 |
| 107 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92814883 |
| 108 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.92014205 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90818713 |
| 110 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90719499 |
| 111 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90303100 |
| 112 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89396139 |
| 113 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.86220947 |
| 114 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85916690 |
| 115 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.85682827 |
| 116 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85070397 |
| 117 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85026847 |
| 118 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84325659 |
| 119 | TBL1_22424771_ChIP-Seq_293T_Human | 0.81633372 |
| 120 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81201606 |
| 121 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.80283463 |
| 122 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77017079 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76792471 |
| 124 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76792471 |
| 125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.75707773 |
| 126 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.74735030 |
| 127 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74521486 |
| 128 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73879478 |
| 129 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.72629012 |
| 130 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.72615998 |
| 131 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.72532089 |
| 132 | * AR_19668381_ChIP-Seq_PC3_Human | 0.72375071 |
| 133 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.72028910 |
| 134 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.71943699 |
| 135 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.70617540 |
| 136 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.70144858 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69907244 |
| 138 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.69502304 |
| 139 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.69160523 |
| 140 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.68991808 |
| 141 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68987362 |
| 142 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.68901749 |
| 143 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.68521626 |
| 144 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.68247765 |
| 145 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.67967170 |
| 146 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.65981182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 6.23803254 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.95818637 |
| 3 | MP0000751_myopathy | 5.00758293 |
| 4 | MP0004036_abnormal_muscle_relaxation | 4.53818018 |
| 5 | * MP0000749_muscle_degeneration | 4.52974819 |
| 6 | MP0003646_muscle_fatigue | 4.36552398 |
| 7 | * MP0004215_abnormal_myocardial_fiber | 4.27710991 |
| 8 | * MP0005330_cardiomyopathy | 3.76762376 |
| 9 | * MP0004087_abnormal_muscle_fiber | 3.32852261 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 3.31436259 |
| 11 | * MP0002972_abnormal_cardiac_muscle | 3.29737443 |
| 12 | * MP0005620_abnormal_muscle_contractility | 2.96171936 |
| 13 | MP0003137_abnormal_impulse_conducting | 2.82435773 |
| 14 | * MP0010630_abnormal_cardiac_muscle | 2.81270495 |
| 15 | MP0000750_abnormal_muscle_regeneration | 2.75940232 |
| 16 | * MP0002106_abnormal_muscle_physiology | 2.70400286 |
| 17 | * MP0008775_abnormal_heart_ventricle | 2.67731014 |
| 18 | MP0001544_abnormal_cardiovascular_syste | 2.62474807 |
| 19 | MP0005385_cardiovascular_system_phenoty | 2.62474807 |
| 20 | MP0004484_altered_response_of | 2.51722657 |
| 21 | MP0003221_abnormal_cardiomyocyte_apopto | 2.42650665 |
| 22 | MP0003828_pulmonary_edema | 2.42625837 |
| 23 | MP0003950_abnormal_plasma_membrane | 2.41857434 |
| 24 | * MP0002269_muscular_atrophy | 2.35580813 |
| 25 | MP0000747_muscle_weakness | 2.35355737 |
| 26 | MP0006138_congestive_heart_failure | 2.35132790 |
| 27 | * MP0005369_muscle_phenotype | 2.19224648 |
| 28 | MP0004130_abnormal_muscle_cell | 2.17794614 |
| 29 | * MP0004085_abnormal_heartbeat | 2.11780528 |
| 30 | * MP0000759_abnormal_skeletal_muscle | 2.03487921 |
| 31 | MP0003567_abnormal_fetal_cardiomyocyte | 1.81568351 |
| 32 | * MP0002127_abnormal_cardiovascular_syste | 1.79087313 |
| 33 | MP0004233_abnormal_muscle_weight | 1.77892104 |
| 34 | MP0001661_extended_life_span | 1.61893366 |
| 35 | * MP0004510_myositis | 1.44499410 |
| 36 | MP0005451_abnormal_body_composition | 1.37688066 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 1.37330183 |
| 38 | MP0002332_abnormal_exercise_endurance | 1.33199641 |
| 39 | * MP0000266_abnormal_heart_morphology | 1.26412831 |
| 40 | MP0004272_abnormal_basement_membrane | 1.15674740 |
| 41 | MP0003122_maternal_imprinting | 1.10339438 |
| 42 | MP0004270_analgesia | 1.09953152 |
| 43 | MP0010368_abnormal_lymphatic_system | 1.03918518 |
| 44 | MP0005670_abnormal_white_adipose | 1.03587562 |
| 45 | MP0002108_abnormal_muscle_morphology | 1.02973460 |
| 46 | MP0000733_abnormal_muscle_development | 0.99115577 |
| 47 | MP0005666_abnormal_adipose_tissue | 0.98433619 |
| 48 | MP0003566_abnormal_cell_adhesion | 0.97338757 |
| 49 | MP0003279_aneurysm | 0.95850699 |
| 50 | MP0008438_abnormal_cutaneous_collagen | 0.94592246 |
| 51 | MP0000343_altered_response_to | 0.94518666 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 0.90586540 |
| 53 | MP0009384_cardiac_valve_regurgitation | 0.85791896 |
| 54 | MP0005165_increased_susceptibility_to | 0.84981440 |
| 55 | * MP0002128_abnormal_blood_circulation | 0.84922777 |
| 56 | MP0000767_abnormal_smooth_muscle | 0.81227846 |
| 57 | MP0005275_abnormal_skin_tensile | 0.78383933 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 0.76019715 |
| 59 | MP0000230_abnormal_systemic_arterial | 0.74829928 |
| 60 | MP0005623_abnormal_meninges_morphology | 0.69612699 |
| 61 | MP0003941_abnormal_skin_development | 0.68244433 |
| 62 | MP0005266_abnormal_metabolism | 0.67133725 |
| 63 | * MP0002925_abnormal_cardiovascular_devel | 0.66183288 |
| 64 | MP0002234_abnormal_pharynx_morphology | 0.65884124 |
| 65 | * MP0002088_abnormal_embryonic_growth/wei | 0.63439422 |
| 66 | MP0001879_abnormal_lymphatic_vessel | 0.63044622 |
| 67 | * MP0003984_embryonic_growth_retardation | 0.62570052 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 0.61821418 |
| 69 | MP0002822_catalepsy | 0.59489190 |
| 70 | MP0005375_adipose_tissue_phenotype | 0.59093469 |
| 71 | MP0005503_abnormal_tendon_morphology | 0.58982862 |
| 72 | MP0003045_fibrosis | 0.57876783 |
| 73 | MP0003123_paternal_imprinting | 0.57387408 |
| 74 | MP0001784_abnormal_fluid_regulation | 0.55808930 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 0.54225035 |
| 76 | MP0000372_irregular_coat_pigmentation | 0.54079742 |
| 77 | MP0003121_genomic_imprinting | 0.53871662 |
| 78 | MP0009250_abnormal_appendicular_skeleto | 0.51179774 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 0.46770971 |
| 80 | * MP0001614_abnormal_blood_vessel | 0.46430957 |
| 81 | MP0002102_abnormal_ear_morphology | 0.45648150 |
| 82 | MP0003385_abnormal_body_wall | 0.44112024 |
| 83 | MP0001672_abnormal_embryogenesis/_devel | 0.43205950 |
| 84 | MP0005380_embryogenesis_phenotype | 0.43205950 |
| 85 | MP0009672_abnormal_birth_weight | 0.42533667 |
| 86 | MP0005248_abnormal_Harderian_gland | 0.41798227 |
| 87 | MP0000462_abnormal_digestive_system | 0.40438520 |
| 88 | MP0004134_abnormal_chest_morphology | 0.38848639 |
| 89 | MP0002638_abnormal_pupillary_reflex | 0.38030134 |
| 90 | MP0005595_abnormal_vascular_smooth | 0.37256446 |
| 91 | MP0002971_abnormal_brown_adipose | 0.35153801 |
| 92 | MP0000534_abnormal_ureter_morphology | 0.35101832 |
| 93 | MP0009697_abnormal_copulation | 0.34565816 |
| 94 | MP0005187_abnormal_penis_morphology | 0.34101182 |
| 95 | MP0005388_respiratory_system_phenotype | 0.32755837 |
| 96 | MP0002133_abnormal_respiratory_system | 0.32755837 |
| 97 | * MP0003948_abnormal_gas_homeostasis | 0.31616099 |
| 98 | MP0008569_lethality_at_weaning | 0.31335550 |
| 99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.30900733 |
| 100 | MP0004197_abnormal_fetal_growth/weight/ | 0.30463382 |
| 101 | MP0004142_abnormal_muscle_tone | 0.30359613 |
| 102 | MP0000013_abnormal_adipose_tissue | 0.30085068 |
| 103 | MP0002168_other_aberrant_phenotype | 0.29408210 |
| 104 | MP0001984_abnormal_olfaction | 0.28247545 |
| 105 | MP0000762_abnormal_tongue_morphology | 0.26928801 |
| 106 | MP0002009_preneoplasia | 0.26114919 |
| 107 | * MP0002114_abnormal_axial_skeleton | 0.26044088 |
| 108 | MP0000003_abnormal_adipose_tissue | 0.26032753 |
| 109 | MP0003115_abnormal_respiratory_system | 0.24251956 |
| 110 | MP0005167_abnormal_blood-brain_barrier | 0.24178681 |
| 111 | MP0001730_embryonic_growth_arrest | 0.23743327 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.23645282 |
| 113 | MP0001175_abnormal_lung_morphology | 0.23523478 |
| 114 | MP0005376_homeostasis/metabolism_phenot | 0.23344963 |
| 115 | MP0001299_abnormal_eye_distance/ | 0.22435019 |
| 116 | MP0005334_abnormal_fat_pad | 0.22411864 |
| 117 | MP0002078_abnormal_glucose_homeostasis | 0.22297674 |
| 118 | MP0004147_increased_porphyrin_level | 0.22226582 |
| 119 | * MP0002086_abnormal_extraembryonic_tissu | 0.22060981 |
| 120 | MP0003879_abnormal_hair_cell | 0.21963371 |
| 121 | MP0001697_abnormal_embryo_size | 0.20313091 |
| 122 | MP0001958_emphysema | 0.20051655 |
| 123 | MP0008004_abnormal_stomach_pH | 0.19662724 |
| 124 | MP0009115_abnormal_fat_cell | 0.18754371 |
| 125 | MP0001943_abnormal_respiration | 0.18695570 |
| 126 | * MP0003935_abnormal_craniofacial_develop | 0.17313101 |
| 127 | MP0000428_abnormal_craniofacial_morphol | 0.17205004 |
| 128 | MP0008770_decreased_survivor_rate | 0.16790821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Sudden death (HP:0001699) | 8.04057229 |
| 2 | Ventricular tachycardia (HP:0004756) | 7.01229335 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 6.74661276 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.25288513 |
| 5 | Atrial fibrillation (HP:0005110) | 6.24198858 |
| 6 | Muscle fiber splitting (HP:0003555) | 6.13008175 |
| 7 | Primary atrial arrhythmia (HP:0001692) | 5.80793101 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 5.61766540 |
| 9 | Supraventricular tachycardia (HP:0004755) | 5.61194225 |
| 10 | * Lipoatrophy (HP:0100578) | 5.53066079 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 5.51715293 |
| 12 | Supraventricular arrhythmia (HP:0005115) | 5.50016312 |
| 13 | * Calf muscle hypertrophy (HP:0008981) | 5.28346725 |
| 14 | * Abnormality of the calf musculature (HP:0001430) | 5.24565944 |
| 15 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.14197685 |
| 16 | Subaortic stenosis (HP:0001682) | 5.14197685 |
| 17 | Syncope (HP:0001279) | 4.94057420 |
| 18 | * Muscle hypertrophy of the lower extremities (HP:0008968) | 4.87976921 |
| 19 | Type 1 muscle fiber predominance (HP:0003803) | 4.71076080 |
| 20 | Myoglobinuria (HP:0002913) | 4.64824196 |
| 21 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.62383036 |
| 22 | Muscle fiber inclusion bodies (HP:0100299) | 4.48663208 |
| 23 | * Dilated cardiomyopathy (HP:0001644) | 4.39740225 |
| 24 | Ventricular arrhythmia (HP:0004308) | 4.37714947 |
| 25 | Prolonged QT interval (HP:0001657) | 4.31856158 |
| 26 | * EMG: myopathic abnormalities (HP:0003458) | 4.27530294 |
| 27 | Increased connective tissue (HP:0009025) | 4.15525370 |
| 28 | Nemaline bodies (HP:0003798) | 3.94701101 |
| 29 | Palpitations (HP:0001962) | 3.89566352 |
| 30 | Bundle branch block (HP:0011710) | 3.89507018 |
| 31 | Rhabdomyolysis (HP:0003201) | 3.79847097 |
| 32 | Asymmetric septal hypertrophy (HP:0001670) | 3.64463495 |
| 33 | * Rimmed vacuoles (HP:0003805) | 3.45399577 |
| 34 | Heart block (HP:0012722) | 3.44127863 |
| 35 | Difficulty running (HP:0009046) | 3.42760430 |
| 36 | Distal arthrogryposis (HP:0005684) | 3.39650393 |
| 37 | Calcaneovalgus deformity (HP:0001848) | 3.37816259 |
| 38 | * Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.36251951 |
| 39 | Abnormal atrioventricular conduction (HP:0005150) | 3.27801431 |
| 40 | Atrioventricular block (HP:0001678) | 3.27117636 |
| 41 | Absent phalangeal crease (HP:0006109) | 3.22872777 |
| 42 | Myotonia (HP:0002486) | 3.17268720 |
| 43 | Ventricular fibrillation (HP:0001663) | 3.03815718 |
| 44 | Abnormal EKG (HP:0003115) | 3.03267682 |
| 45 | Malignant hyperthermia (HP:0002047) | 3.00442931 |
| 46 | Deformed tarsal bones (HP:0008119) | 2.95965280 |
| 47 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.95163505 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.87802447 |
| 49 | Difficulty climbing stairs (HP:0003551) | 2.85789118 |
| 50 | Left ventricular hypertrophy (HP:0001712) | 2.85580654 |
| 51 | Fetal akinesia sequence (HP:0001989) | 2.80196581 |
| 52 | Areflexia of lower limbs (HP:0002522) | 2.73897252 |
| 53 | * Neck muscle weakness (HP:0000467) | 2.72035394 |
| 54 | Abnormal finger flexion creases (HP:0006143) | 2.70669090 |
| 55 | Bulbar palsy (HP:0001283) | 2.69916895 |
| 56 | * Palmoplantar keratoderma (HP:0000982) | 2.69163210 |
| 57 | EMG: neuropathic changes (HP:0003445) | 2.61117967 |
| 58 | Muscle stiffness (HP:0003552) | 2.57796426 |
| 59 | Increased variability in muscle fiber diameter (HP:0003557) | 2.53362445 |
| 60 | Round ear (HP:0100830) | 2.51892528 |
| 61 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.51089131 |
| 62 | Fatigable weakness (HP:0003473) | 2.37141934 |
| 63 | Abnormality of the neuromuscular junction (HP:0003398) | 2.37141934 |
| 64 | Weak cry (HP:0001612) | 2.35669764 |
| 65 | Ragged-red muscle fibers (HP:0003200) | 2.30870514 |
| 66 | Acute necrotizing encephalopathy (HP:0006965) | 2.29121532 |
| 67 | Conjunctival hamartoma (HP:0100780) | 2.28969092 |
| 68 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.28548720 |
| 69 | Hyperkalemia (HP:0002153) | 2.22519201 |
| 70 | Hypoplastic ischia (HP:0003175) | 2.20087535 |
| 71 | Slender build (HP:0001533) | 2.19370643 |
| 72 | Double outlet right ventricle (HP:0001719) | 2.17577630 |
| 73 | Congenital malformation of the right heart (HP:0011723) | 2.17577630 |
| 74 | Scapular winging (HP:0003691) | 2.16911555 |
| 75 | Hepatic necrosis (HP:0002605) | 2.14728022 |
| 76 | Hypoglycemic coma (HP:0001325) | 2.11843256 |
| 77 | Gowers sign (HP:0003391) | 2.11598511 |
| 78 | Waddling gait (HP:0002515) | 2.10590738 |
| 79 | * Generalized muscle weakness (HP:0003324) | 2.05718890 |
| 80 | Popliteal pterygium (HP:0009756) | 2.05458407 |
| 81 | Congestive heart failure (HP:0001635) | 2.04480117 |
| 82 | Myopathic facies (HP:0002058) | 2.03683805 |
| 83 | Neoplasm of the adrenal gland (HP:0100631) | 2.01855923 |
| 84 | Sudden cardiac death (HP:0001645) | 2.01793069 |
| 85 | Distal lower limb amyotrophy (HP:0008944) | 2.01511136 |
| 86 | Exercise intolerance (HP:0003546) | 2.01002834 |
| 87 | Hip contracture (HP:0003273) | 1.99470937 |
| 88 | Pheochromocytoma (HP:0002666) | 1.97021260 |
| 89 | Patent foramen ovale (HP:0001655) | 1.96500860 |
| 90 | Ketoacidosis (HP:0001993) | 1.95737167 |
| 91 | Limited hip movement (HP:0008800) | 1.95124250 |
| 92 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.93270851 |
| 93 | Abnormality of the ischium (HP:0003174) | 1.92595009 |
| 94 | Hypoplastic left heart (HP:0004383) | 1.91702247 |
| 95 | Spinal rigidity (HP:0003306) | 1.91092690 |
| 96 | Progressive muscle weakness (HP:0003323) | 1.90168078 |
| 97 | Progressive macrocephaly (HP:0004481) | 1.90057482 |
| 98 | Abnormality of the calcaneus (HP:0008364) | 1.87173746 |
| 99 | Metatarsus adductus (HP:0001840) | 1.86893967 |
| 100 | Acute encephalopathy (HP:0006846) | 1.84075778 |
| 101 | * Muscular dystrophy (HP:0003560) | 1.83451704 |
| 102 | Toxemia of pregnancy (HP:0100603) | 1.83174476 |
| 103 | Increased CSF lactate (HP:0002490) | 1.83070164 |
| 104 | Frequent falls (HP:0002359) | 1.81946930 |
| 105 | Type 2 muscle fiber atrophy (HP:0003554) | 1.81820888 |
| 106 | Hepatocellular necrosis (HP:0001404) | 1.81336077 |
| 107 | Mitochondrial inheritance (HP:0001427) | 1.80738812 |
| 108 | Abnormality of glycolysis (HP:0004366) | 1.79554423 |
| 109 | Increased serum pyruvate (HP:0003542) | 1.79554423 |
| 110 | Hamartoma of the eye (HP:0010568) | 1.78401426 |
| 111 | Lower limb amyotrophy (HP:0007210) | 1.78186091 |
| 112 | Ulnar deviation of finger (HP:0009465) | 1.77549635 |
| 113 | Limb-girdle muscle atrophy (HP:0003797) | 1.77187325 |
| 114 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.77046248 |
| 115 | Proximal amyotrophy (HP:0007126) | 1.76284666 |
| 116 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.74682970 |
| 117 | Hyperglycemia (HP:0003074) | 1.73044290 |
| 118 | Neuroendocrine neoplasm (HP:0100634) | 1.72932203 |
| 119 | Long clavicles (HP:0000890) | 1.71621867 |
| 120 | Ulnar deviation of the wrist (HP:0003049) | 1.70420713 |
| 121 | Facial diplegia (HP:0001349) | 1.69777783 |
| 122 | Oligomenorrhea (HP:0000876) | 1.69607981 |
| 123 | * Abnormality of the foot musculature (HP:0001436) | 1.67751470 |
| 124 | Cerebral edema (HP:0002181) | 1.67500590 |
| 125 | Hypoplastic heart (HP:0001961) | 1.66601726 |
| 126 | Broad metatarsal (HP:0001783) | 1.65997186 |
| 127 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.65253624 |
| 128 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.65253624 |
| 129 | Nonprogressive disorder (HP:0003680) | 1.64870328 |
| 130 | * Foot dorsiflexor weakness (HP:0009027) | 1.61903499 |
| 131 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.59487041 |
| 132 | Muscle fiber atrophy (HP:0100295) | 1.57491905 |
| 133 | Aplasia of the musculature (HP:0100854) | 1.57378701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.69922949 |
| 2 | MYLK | 4.46881895 |
| 3 | ZAK | 3.83600872 |
| 4 | DMPK | 3.66449479 |
| 5 | PHKG1 | 3.54503245 |
| 6 | PHKG2 | 3.54503245 |
| 7 | PIK3CA | 3.33030677 |
| 8 | PKN2 | 3.12286568 |
| 9 | * OBSCN | 3.02544550 |
| 10 | STK24 | 2.99074418 |
| 11 | LMTK2 | 2.80000994 |
| 12 | MUSK | 2.77220629 |
| 13 | PDK3 | 2.72636152 |
| 14 | PDK4 | 2.72636152 |
| 15 | STK38L | 1.99828809 |
| 16 | NEK1 | 1.94950673 |
| 17 | TIE1 | 1.85626620 |
| 18 | TRIB3 | 1.82470702 |
| 19 | INSRR | 1.65106754 |
| 20 | ILK | 1.63296909 |
| 21 | PDK2 | 1.59543130 |
| 22 | BCKDK | 1.56100010 |
| 23 | TRPM7 | 1.45312286 |
| 24 | CAMK2D | 1.44517144 |
| 25 | CDC42BPA | 1.44473882 |
| 26 | PINK1 | 1.32653208 |
| 27 | PIK3CG | 1.27136783 |
| 28 | MAP3K7 | 1.24272110 |
| 29 | ROCK1 | 1.23473367 |
| 30 | CCNB1 | 1.17930597 |
| 31 | STK4 | 1.13811711 |
| 32 | PRKD1 | 1.12384755 |
| 33 | FLT3 | 1.11111256 |
| 34 | MARK1 | 1.10038649 |
| 35 | PAK3 | 1.08448970 |
| 36 | LIMK1 | 1.06514235 |
| 37 | RIPK1 | 1.00179147 |
| 38 | GRK7 | 0.99647980 |
| 39 | PRKAA2 | 0.99229852 |
| 40 | LATS1 | 0.97480008 |
| 41 | EEF2K | 0.96452224 |
| 42 | MAPK12 | 0.96212810 |
| 43 | PRKAA1 | 0.96111852 |
| 44 | SIK1 | 0.93456271 |
| 45 | MAP2K3 | 0.91160836 |
| 46 | MAP3K5 | 0.88580603 |
| 47 | MAP2K4 | 0.88013851 |
| 48 | DAPK3 | 0.84617350 |
| 49 | WNK4 | 0.83367566 |
| 50 | WNK1 | 0.83157497 |
| 51 | PKN1 | 0.80655343 |
| 52 | MAP3K3 | 0.78404109 |
| 53 | PTK2B | 0.69432674 |
| 54 | ERBB3 | 0.66806352 |
| 55 | PDGFRA | 0.66711895 |
| 56 | KDR | 0.64088589 |
| 57 | AKT2 | 0.64036542 |
| 58 | MOS | 0.63225087 |
| 59 | ROCK2 | 0.62036995 |
| 60 | CAMK1 | 0.61034666 |
| 61 | MAPKAPK3 | 0.60558343 |
| 62 | NUAK1 | 0.58814129 |
| 63 | CAMK2A | 0.58413010 |
| 64 | NLK | 0.57882350 |
| 65 | CAMK4 | 0.57876003 |
| 66 | PRKACB | 0.57633561 |
| 67 | EPHA3 | 0.56544188 |
| 68 | STK3 | 0.56476651 |
| 69 | PRKD3 | 0.55170011 |
| 70 | MAPK4 | 0.54986133 |
| 71 | STK39 | 0.53500860 |
| 72 | NME1 | 0.49232002 |
| 73 | NEK9 | 0.47245287 |
| 74 | AKT3 | 0.46617449 |
| 75 | STK38 | 0.46489403 |
| 76 | RPS6KC1 | 0.44779824 |
| 77 | RPS6KL1 | 0.44779824 |
| 78 | MAPK11 | 0.44764789 |
| 79 | CAMK2B | 0.43705201 |
| 80 | MAP3K13 | 0.41703480 |
| 81 | * PRKACA | 0.40847505 |
| 82 | MAP3K10 | 0.39124069 |
| 83 | MAP2K1 | 0.38895187 |
| 84 | RET | 0.38198361 |
| 85 | SGK494 | 0.37780770 |
| 86 | SGK223 | 0.37780770 |
| 87 | CAMK2G | 0.36880496 |
| 88 | KSR2 | 0.36692181 |
| 89 | PRKCE | 0.36000684 |
| 90 | LATS2 | 0.35933367 |
| 91 | PRKACG | 0.35414129 |
| 92 | MAP3K6 | 0.35215263 |
| 93 | RPS6KA6 | 0.34900411 |
| 94 | TNIK | 0.34636687 |
| 95 | FGFR1 | 0.34354766 |
| 96 | MARK3 | 0.33614704 |
| 97 | MARK2 | 0.33495686 |
| 98 | DYRK1B | 0.33430449 |
| 99 | FGFR3 | 0.32532186 |
| 100 | MAP2K6 | 0.31742324 |
| 101 | PAK2 | 0.31611696 |
| 102 | RPS6KB1 | 0.30612466 |
| 103 | MTOR | 0.30234113 |
| 104 | MAPK10 | 0.30039999 |
| 105 | * PRKG1 | 0.29416536 |
| 106 | PRKCH | 0.29139691 |
| 107 | STK11 | 0.27671650 |
| 108 | BCR | 0.27470243 |
| 109 | PRKG2 | 0.27414876 |
| 110 | TGFBR2 | 0.27200583 |
| 111 | SGK3 | 0.26528729 |
| 112 | PDK1 | 0.24529391 |
| 113 | MAP3K1 | 0.24210098 |
| 114 | EPHB2 | 0.24115856 |
| 115 | FRK | 0.22890552 |
| 116 | RAF1 | 0.21434324 |
| 117 | JAK1 | 0.20986152 |
| 118 | TESK1 | 0.20832956 |
| 119 | SGK2 | 0.20415634 |
| 120 | RPS6KA1 | 0.19910879 |
| 121 | SGK1 | 0.19635209 |
| 122 | RPS6KA3 | 0.18709708 |
| 123 | PDGFRB | 0.18220944 |
| 124 | ICK | 0.17791259 |
| 125 | PTK6 | 0.17650176 |
| 126 | MAPK13 | 0.16847530 |
| 127 | AKT1 | 0.15348516 |
| 128 | RPS6KB2 | 0.15316383 |
| 129 | MAPK7 | 0.14211399 |
| 130 | MELK | 0.13905894 |
| 131 | PRKDC | 0.13367927 |
| 132 | FER | 0.12652888 |
| 133 | PRKCQ | 0.12579301 |
| 134 | EPHB1 | 0.11892445 |
| 135 | JAK2 | 0.11767986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 5.44269406 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.29704053 |
| 3 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.70172248 |
| 4 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.54484121 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.54698987 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.28586281 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.99822687 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.77747786 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.50549494 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.32222937 |
| 11 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.32042265 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.21101890 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.14780682 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.03649069 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.96752900 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.92563480 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.91301017 |
| 18 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.71090166 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.69031817 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.53835376 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46521938 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.41611289 |
| 23 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.38116436 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30196319 |
| 25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.27509496 |
| 26 | Insulin resistance_Homo sapiens_hsa04931 | 1.24733060 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18490870 |
| 28 | Tight junction_Homo sapiens_hsa04530 | 1.18318845 |
| 29 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.11646216 |
| 30 | Focal adhesion_Homo sapiens_hsa04510 | 1.10593690 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.04472128 |
| 32 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.02987566 |
| 33 | Galactose metabolism_Homo sapiens_hsa00052 | 0.95184665 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.94498257 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94252580 |
| 36 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.89480727 |
| 37 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87947571 |
| 38 | Adherens junction_Homo sapiens_hsa04520 | 0.87831629 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.86067523 |
| 40 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.83280217 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83246776 |
| 42 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.79538489 |
| 43 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76440670 |
| 44 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76364935 |
| 45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75286923 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.72360468 |
| 47 | Lysine degradation_Homo sapiens_hsa00310 | 0.70153630 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 0.66773578 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65837008 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62542246 |
| 51 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62020579 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59582236 |
| 53 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55963462 |
| 54 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50982025 |
| 55 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50833405 |
| 56 | Insulin secretion_Homo sapiens_hsa04911 | 0.50754767 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48338072 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47990569 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47736685 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45532261 |
| 61 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45247497 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 0.45209006 |
| 63 | Circadian entrainment_Homo sapiens_hsa04713 | 0.44165446 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43211064 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42406779 |
| 66 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41179737 |
| 67 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.40644601 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 0.39728903 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34989708 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.34947371 |
| 71 | Glioma_Homo sapiens_hsa05214 | 0.33697939 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32915188 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31761497 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31714729 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31704389 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.30635561 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28485799 |
| 78 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.28329440 |
| 79 | Long-term depression_Homo sapiens_hsa04730 | 0.28297131 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.26920228 |
| 81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.26601174 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26061644 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25891827 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25732346 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25367996 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25358181 |
| 87 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.21777922 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21103147 |
| 89 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.20775767 |
| 90 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.20600454 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.20298562 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.20097289 |
| 93 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.19472273 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.18983083 |
| 95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.16983619 |
| 96 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.16500476 |
| 97 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.15542543 |
| 98 | Melanogenesis_Homo sapiens_hsa04916 | 0.14378985 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.14054132 |
| 100 | Olfactory transduction_Homo sapiens_hsa04740 | 0.13463020 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.13362038 |
| 102 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.11678917 |
| 103 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.11216618 |
| 104 | Peroxisome_Homo sapiens_hsa04146 | 0.11102081 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.10248971 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.09790134 |
| 107 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.08908572 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.08794222 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08569440 |
| 110 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.06636056 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.05743433 |
| 112 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.05421530 |
| 113 | Bile secretion_Homo sapiens_hsa04976 | 0.05201821 |
| 114 | Pathways in cancer_Homo sapiens_hsa05200 | 0.04434201 |
| 115 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.03866443 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.03448242 |

